ANTIBODIES THAT SPECIFICALLY BIND TO TL1A
Recombinantly expressed variant antibodies that have enhanced affinity for TL1A and enhanced potency relative to the parent antibody from which they were derived are provided. The antibodies inhibit the interaction between TL1A and the death receptor 3 (DR3). The antibodies, or a composition thereof...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English Slovenian |
Published |
30.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!